Drug Development Market Research Reports & Industry Analysis

The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.

Drug Development Market Research and Industry Forecasts

  • Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
  • Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
  • The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.

MarketResearch.com: Your Dedicated Partner 

Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.

...Show More ...Show Less


Drug Development Industry Research & Market Reports

  • Small Molecule Drug Discovery

    ... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Oncology Therapeutic Area, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$38.9 Billion by ... Read More

  • Gynecological Cancer Drugs

    ... at a CAGR of 5.1% over the analysis period 2024-2030. Cervical Cancer, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$10.3 Billion by the end of ... Read More

  • Live Cell Encapsulation

    ... at a CAGR of 3.8% over the analysis period 2024-2030. Alginate, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$117.8 Million by the end of the ... Read More

  • Drug Discovery Outsourcing

    ... at a CAGR of 6.5% over the analysis period 2024-2030. Lead Identification & Candidate Optimization, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$3.0 Billion by ... Read More

  • Cancer Immunotherapy Drug Discovery Outsourcing

    ... Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 13.4% CAGR and reach US$1.5 Billion ... Read More

  • Viral Clearance

    ... CAGR of 18.2% over the analysis period 2024-2030. Recombinant Proteins, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$467.7 Million by the end of the analysis ... Read More

  • MRSA Drugs

    ... CAGR of 4.5% over the analysis period 2024-2030. Glycopeptides & Lipoglycopeptides, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$726.5 Million by the end of the ... Read More

  • Biosimulation Technology

    ... CAGR of 15.6% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$5.7 Billion by the end of the analysis period. ... Read More

  • Stable Isotope Labeled Compounds

    ... 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Deuterium, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$183.4 Million by the end ... Read More

  • Organs-on-Chips

    ... 35.3% over the analysis period 2024-2030. Liver, one of the segments analyzed in the report, is expected to record a 36.6% CAGR and reach US$206.0 Billion by the end of the analysis period. Growth in ... Read More

  • Cloud-Based Drug Discovery Platforms

    ... 2030, growing at a CAGR of 14.3% over the analysis period 2024-2030. Pharmaceutical Vendors End-Use, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$3.0 Billion by ... Read More

  • mRNA Platform

    ... CAGR of -2.7% over the analysis period 2024-2030. Covid-19 Vaccine, one of the segments analyzed in the report, is expected to record a -6.3% CAGR and reach US$102.1 Billion by the end of the analysis ... Read More

  • Artificial Intelligence (AI) in Drug Discovery

    ... reach US$13.5 Billion by 2030, growing at a CAGR of 26.4% over the analysis period 2024-2030. Oncology, one of the segments analyzed in the report, is expected to record a 22.8% CAGR and reach US$3.0 ... Read More

  • Hepatitis C Treatment

    ... at a CAGR of 10.7% over the analysis period 2024-2030. HCV Protease Inhibitors, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$25.3 Billion by the end ... Read More

  • Single-Use Bioprocessing

    ... CAGR of 20.8% over the analysis period 2024-2030. Single-Use Media Bags & Containers, one of the segments analyzed in the report, is expected to record a 22.6% CAGR and reach US$29.9 Billion by the end ... Read More

  • Drug Discovery Services

    ... at a CAGR of 1.8% over the analysis period 2024-2030. Medicinal Chemistry Services, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$31.6 Billion by the end ... Read More

  • Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment

    ... Billion by 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Medication, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$5.5 Billion by ... Read More

  • Antivirals Drug

    ... CAGR of 4.2% over the analysis period 2024-2030. DNA Polymerase Inhibitors, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$14.7 Billion by the end of the ... Read More

  • Label-free Array Systems

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Surface Plasmon Resonance (SPR), one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.8 Billion by the ... Read More

  • Fragment-based Drug Discovery

    ... at a CAGR of 8.8% over the analysis period 2024-2030. Fragment Screening, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$1.1 Billion by the end of ... Read More

  • Peptide Synthesis

    ... CAGR of 4.3% over the analysis period 2024-2030. Reagent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$161.7 Million by the end of the analysis period. ... Read More

  • Pathology Instruments

    ... CAGR of 5.6% over the analysis period 2024-2030. Molecular Diagnostics, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.7 Billion by the end of the analysis ... Read More

  • Drug Discovery Informatics

    ... at a CAGR of 7.7% over the analysis period 2024-2030. Sequencing & Target Data Analysis, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$1.7 Billion by ... Read More

  • In Vivo CRO Market Size, Share & Trends Analysis Report By Model Type (Rodent Based, Non-rodent Based), By Modality (Small Molecule, Large Molecule), By Indication, By GLP Type (Non GLP, GLP Toxicology), By Region, )- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

    ... a CAGR of 8.34% from 2024 to 2033. In Vivo CRO Market Key Takeaways In 2023, the rodent based segment dominated the market with a revenue share of 81.76%. The non-rodent based segment is expected ... Read More

  • Automated Cell Counters Market, By Product (Instruments(Spectrophotometers, Flow Cytometers, Hemocytometers, Automated Cell Counters, Microscopes Others), Consumables & Accessories(Reagents & Kits, Microplates and Others), and Software), By End User (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), By Application (Medical Diagnostics, Drug Discovery, Cancer Research, Immunology, Virology, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

    ... eliminating the need for manual counting methods. The global market for automated cell counters is witnessing significant growth due tthe increasing demand for cell-based research and the rising prevalence of chronic diseases. The automated cell ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings